![Disconnection of drug-response and placebo-response in acute-phase antipsychotic drug trials on schizophrenia? Meta-regression analysis | Neuropsychopharmacology Disconnection of drug-response and placebo-response in acute-phase antipsychotic drug trials on schizophrenia? Meta-regression analysis | Neuropsychopharmacology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41386-019-0440-6/MediaObjects/41386_2019_440_Fig1_HTML.png)
Disconnection of drug-response and placebo-response in acute-phase antipsychotic drug trials on schizophrenia? Meta-regression analysis | Neuropsychopharmacology
![Cost of Relapse Management in Patients with Schizophrenia in Italy and Spain: Comparison Between Lurasidone and Quetiapine XR | SpringerLink Cost of Relapse Management in Patients with Schizophrenia in Italy and Spain: Comparison Between Lurasidone and Quetiapine XR | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40261-020-00944-0/MediaObjects/40261_2020_944_Fig2_HTML.png)
Cost of Relapse Management in Patients with Schizophrenia in Italy and Spain: Comparison Between Lurasidone and Quetiapine XR | SpringerLink
![Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies - The Lancet Psychiatry Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies - The Lancet Psychiatry](https://www.thelancet.com/cms/attachment/064281c8-6e6b-438b-91fd-1139e1d974f4/gr1.gif)